1 Min Read
July 6 (Reuters) - Trovagene Inc
* Trovagene engages leading cro in aml to conduct phase 1b/2 trial of pcm-075 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.